We hypothesize that the effects of rs7830 on ESRD might be due to NOS3 rather than ATG9B. In fact, polymorphisms in NOS3 have been associated with atherosclerotic vascular diseases [24], renal dysfunction [25], and advanced diabetic nephropathy [26]. This evidence concerns the gene ATG9B and Abnormal renal physiology.